Cargando…
Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review
PURPOSE: Cancer patients with COVID-19 likely express biomarker changes in circulation. However, the biomarkers used in SARS-CoV-2 infected cancer patients for COVID-19 severity and prognosis are largely unclear. Therefore, this systematic review aims to determine what biomarkers were measured in ca...
Autores principales: | Lee, Te-An, Wang, Shih-Han, Kuo, Chun-Tse, Li, Chia-Wei, McCullough, Louise D., Bello, Dhimiter, Lai, Yun-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057983/ https://www.ncbi.nlm.nih.gov/pubmed/35523009 http://dx.doi.org/10.1016/j.tranon.2022.101443 |
Ejemplares similares
-
Biomarkers in long COVID-19: A systematic review
por: Lai, Yun-Ju, et al.
Publicado: (2023) -
Elevated Urinary Biomarkers of Oxidative Damage in Photocopier Operators following Acute and Chronic Exposures
por: Zhang, Yipei, et al.
Publicado: (2022) -
Chemokines and Cytokines as Salivary Biomarkers for the Early Diagnosis of Oral Cancer
por: Prasad, Gareema, et al.
Publicado: (2013) -
Cerebrovascular disease in women
por: Kumar, Aditya, et al.
Publicado: (2021) -
Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)